¥È¥Ã¥× º¹Ê¬ °ìÍ÷ ¥½¡¼¥¹ ¸¡º÷ ¥Ø¥ë¥× PDF RSS ¥í¥°¥¤¥ó

ÂÛ»ùºÎ·ì¡ÊÂÛ»ùÂÛÈ×µ¡Ç½É¾²Á¡Ë

ÂÛ»ùÂÛÈ×µ¡Ç½É¾²Á¤òÌÜŪ¤È¤·¤¿ÂÛ»ùºÎ·ì

¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡Ê¼¼·î ½ß¡¡2002ǯ¡Ë

¤³¤Îʸ¾Ï¤Ï2002ǯ¤Ë½ñ¤«¤ì¤¿¤â¤Î¤Ç¤¹¡¥Åö»þ¡¤ÂÛ»ù¾õÂÖ¤òɾ²Á¤¹¤ë¤¿¤á¤ËPUBS¤¬¤ª¤³¤Ê¤ï¤ì¤ë¤³¤È¤¬¤·¤Ð¤·¤Ð¤¢¤ê¤Þ¤·¤¿¡¥½ÐÀ¸»þ¤Î»ù¤Î¾õÂÖ¤ò¤â¤Ã¤È¤â¤è¤¯È¿±Ç¤¹¤ë¤Î¤¬çÁÂÓÆ°Ì®¤Î·ì±Õ¥¬¥¹ÃͤǤ¢¤ë¤³¤È¤Ï¤¢¤­¤é¤«¤Ç¤¢¤ê¡¤Æ±ÍͤËÂÛ»ù¤Î¾õÂÖ¤ò¤â¤Ã¤È¤â¤è¤¯É¾²Á¤Ç¤­¤ë¤Î¤âÂÛ»ù·ì¤Î·ì±Õ¥¬¥¹ÃͤǤ¢¤ë¤³¤È¤Ë°ÛÏÀ¤Ï¾¯¤Ê¤¤¤Ç¤·¤ç¤¦¡¥PUBS¤Ë¤è¤ë¥Ç¡¼¥¿¤ÏÂÛ»ùÀ¸Íý¤ÎÍý²ò¤òÂ礭¤¯Â¥¤·¤¿¤Î¤Ç¤¹¤¬¡¤Æ±»þ¤ËÈ󿯽±Åª¤ÊÂÛ»ù¿´Çï¿ô¥â¥Ë¥¿¥ê¥ó¥°¤Î½ê¸«¤òÀ¸ÍýŪ¤Ë´ðÁ䍱¤ë¹×¸¥¤ò²Ì¤¿¤·¤Þ¤·¤¿¡¥¤½¤Î¸å¡¤ÂÛ»ù¾õÂÖ¤Îɾ²Á¤ÏÈ󿯽±Åª¤ÊÊýË¡¤Ë¤è¤ë¤Î¤¬¼çή¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡¥

 ¤Ï¤¸¤á¤Ë

ÂÛ»ù¡¦¿·À¸»ù¤Îasphyxia¤Ï¡¤¤ï¤ì¤ï¤ì»º²Ê°å¤Ë¤È¤Ã¤Æ¤â¤Ã¤È¤â´Ø¿´¤Î¤¢¤ë¼çÂê¤Ç¤¢¤ë¤¬¡¤¤½¤Î¿ÇÃǤˤϻù¤Î·ì±Õ¥¬¥¹¤ª¤è¤ÓpH¤Î¬Ä꤬ÉԲķç¤È¤¤¤¨¤ë¤Û¤É½ÅÍפǤ¢¤ë¡¥ÂÛ»ù·ì¤Î¥µ¥ó¥×¥ê¥ó¥°¤Ë¤Ï¡¤­¡Ç¥¿±Ãæ¤ÎĶ²»ÇÈ¥¬¥¤¥É²¼¤Ë¤è¤ë·ÐÈéŪçÁÂÓ·ìºÎ¼è¡Êpercutaneous umbilical blocd sampling; PUBS¡Ë¡¤­¢Ê¬ÊÚÃæ¤Î»ùƬ¤«¤é¤ÎËö¾¿·ìºÎ·ì¡Ê¤¤¤ï¤æ¤ëSalingË¡¡Ë¡¤­£Ê¬ÊÚ¸å¤ÎçÁÂÓ¥¯¥é¥ó¥×¤Ë¤è¤ëçÁÂÓ·ìºÎ·ì¤Î»°¤Ä¤¬¤¢¤ë(1)¡¥ËܹƤǤϡ¤Ê¬ÊÚÁ°ÂÛ»ùɾ²Á¤Î°ìÊýË¡¤È¤·¤Æ¡¤ÆäËPUBS¤Ë¤è¤ëÂÛ»ù·ì±Õ¥¬¥¹Â¬Äê¤Ë¤Ä¤¤¤Æ¼è¤ê¾å¤²¤Æ²òÀ⤹¤ë¡¥

PUBS¤ÎÉáµÚ¤Ë¤è¤Ã¤ÆÂÛ»ù½Û´Ä¤Ø¤ÎľÀÜŪ¤Ê¥¢¥×¥í¡¼¥Á¤¬²Äǽ¤È¤Ê¤ê¡¤ÂÛ»ù¼À´µ¤Ë¤¿¤¤¤¹¤ëɾ²Á¤È¼£ÎŤÎξÌ̤ˤª¤¤¤Æ¿¤¯¤Î¿·¤·¤¤»î¤ß¤¬¤Ê¤µ¤ì¤Æ¤¤¤ë¡¥ÂÛ»ùwell-beingɾ²Á¤Î¤¿¤á¤Î·ì±Õ¥¬¥¹¤ª¤è¤Ó»À±ö´ðÊ¿¹Õ¬Äê¤â¤½¤Î¤Ò¤È¤Ä¤Ç¤¢¤ë¡¥¤¿¤È¤¨¤Ð¡¤»ÒµÜÆâÂÛ»ùȯ°éÃÙ±ä¡Êintrauterine growth restriction; IUGR¡Ë¤Ë¤ª¤¤¤Æ¡¤»ÒµÜÆâ¤ÇËýÀ­Åª¤ËÄã»ÀÁÇ·ì¾É¡Êhypoxemia¡Ë¤ä¥¢¥·¥É¡¼¥·¥¹¤òÄ褹¤ëÂÛ»ù¤¬Â¸ºß¤¹¤ë¤³¤È¤Ï¤è¤¯ÃΤé¤ì¤Æ¤¤¤ë¡¥°ìÈ̤ËÂÛ»ù¥â¥Ë¥¿¥ê¥ó¥°¤È¸Æ¤Ð¤ì¤ë¤â¤Î¤Î½ÅÍפÊÌò³ä¤Î¤Ò¤È¤Ä¤Ï¡¤¤³¤Î¤è¤¦¤ÊÂÛ»ù¤¬ÂÛÆâ»àË´¤ä¿À·Ð³ØŪ¾ã³²¤òµ¯¤³¤¹Á°¤Ë¸«¤Ä¤±¤À¤·¡¤µÞ®¿ëÊÚ¤äÂÛ³°¼£ÎŤʤɤΰå³ØŪ²ðÆþ¤Î·èÄê¤ò¤¹¤ë¼ê½õ¤±¤Ë¤¢¤ë.¡¥PUBS¤Ï¡¤¾¯¤Ê¤¯¤È¤âÅö½é¤Ï¡¤¤³¤ÎƱÄê¤Î¤¿¤á¤Î¤â¤Ã¤È¤âľÀÜŪ¤Ç³Î¤«¤ÊÊýË¡¤È¹Í¤¨¤é¤ì¡¤Â¿¤¯¤ÎÎ×¾²¸¦µæ¤¬¤Ê¤µ¤ì¤Æ¤­¤¿¡¥°Ê²¼¤Ç¤Ï¤½¤ì¤é¤ÎÊó¹ð¤ò³µ³ç¤·¡¤çÁÂÓÀÅÌ®·ì¤Ë¤ª¤±¤ë·ì±Õ¥¬¥¹¡¤pH¤ÎÀµ¾ïÃÍ¡¤¤ª¤è¤ÓPUBS¤ÎŬ±þ¤È°ÕµÁ¡¤¸Â³¦¤Ê¤É¤Ë¤Ä¤¤¤Æ½Ò¤Ù¤ë¡¥

¡¡

 1¡¥ÂÛ»ù¤Ë¤ª¤±¤ë·ì±Õ¥¬¥¹¤È»À±ö´ðÊ¿¹Õ¬Äê¤Î´ðÁÃ

ÂÛ»ù·ì¤ÎpHÃͤϤ½¤ì¤¬Ç¥¿±Ãæ¤äʬÊÚÁ°¸å¤Î¤É¤Î»þÅÀ¤Ç¤ÎºÎ·ì¤Ë¤è¤ë¤â¤Î¤Ç¤¢¤Ã¤Æ¤â¡¤ÂÛ»ù¾õÂ֤οÇÃǤÈͽ¸å¿äÄê¤Î¤¿¤á¤Ë½ÅÍפʰյÁ¤ò¤â¤Ä¡¥ÂÛ»ù¤Î½Å¾É¥¢¥·¥É¡¼¥·¥¹¤Ï°ìÈ̤˼þ»º´ü»àË´¤ä¿À·Ð³ØŪ¸å°ä¾É¤Ê¤É¤Î¥ê¥¹¥¯¤ò¹â¤á¤ë¤³¤È¤Ë¤Ê¤ë¡¥

a.·ì±Õ¥¬¥¹¤ª¤è¤ÓpH¤Î²ò¼á

ÂÛ»ù¤Ë¤ª¤±¤ë¥¢¥·¥É¡¼¥·¥¹¤ÏÄ̾Âå¼ÕÀ­¤ª¤è¤Ó¸ÆµÛÀ­¤Îξ¼Ô¤¬Æþ¤Ã¤¿º®¹çÀ­¥¢¥·¥É¡¼¥·¥¹¤Ç¤¢¤ë¡¥¤¹¤Ê¤ï¤Á¡¤ºÙ˦³°±Õ¤Ë¤ª¤±¤ë±ö´ð·ç»¡Êextracellular base deficit¡Ë¤Èú»À¥¬¥¹Ê¬°µ(PCO2)¤Î¾å¾º¤òȼ¤¦¡¥±ö´ð·ç»¤ÏÄã»ÀÁǤˤè¤ëÂÛ»ùÁÈ¿¥Ãæ¤Î·ùµ¤À­Âå¼Õ¤ÈÆý»À»ºÀ¸¤ò°ÕÌ£¤¹¤ë¡¥PCO2¤Î¾å¾º¤ÏÂÛÈפˤª¤±¤ëCO2³È»¶¤Î¸º¾¯¤ò¾¯¤ò¼¨¤¹¡¥

ÂÛ»ù¤ÎPCO2¥ì¥Ù¥ë¤ÏÀ®¿Í¤ÈÂ礭¤¯ÊѤï¤é¤Ê¤¤¡¥CO2¤ÎËìÆ©²áÀ­¤Ï¹â¤¤¤Î¤Ç¡¤ÂÛ»ùÂÛÈ×·ìή¤ÎÄã²¼¤¢¤ë¤¤¤Ï¤«¤Ê¤ê¤ÎÂÛÈ×µ¡Ç½ÉÔÁ´¤¬¤Ê¤¤¤«¤®¤ê¡¤ÊìÂν۴ÄÃæ¤Ë³È»¶¤·¤ÆÊìÂΤ˶ᤤ¥ì¥Ù¥ë¤ÇÊ¿¹Õ¤È¤Ê¤ë¡¥Àµ¾ï¤ÊÇ¥ÉØÊìÂΤϰìÈ̤˲á¸ÆµÛ¤Î·¹¸þ¤Ë¤¢¤ê¡¤PCO2¤¬Ä㤤Äãú»À¥¬¥¹·ì¾É¡Êhypocapnia¡Ë¤È¤Ê¤ë¡¥ ¤³¤Î·ÚÅ٤ʸƵÛÀ­¥¢¥ë¥«¥í¡¼¥·¥¹¤Î¤¿¤á¡¤Ç¥Éؤηì±Õ¤ÎpH¤Ï¤ä¤ä¹â¤¤¡¥çÁÂÓ·ì¤ÎpH¤ÏÆ°ÀÅÌ®¤È¤âÊìÂηìpH¤è¤ê¼ã´³Ä㤯¡¤¤¿¤È¤¨¤Ð»ÒµÜÀÅÌ®¤ÈçÁÂÓÀÅÌ®¤ÎpH¤Îº¹¤Ï°ìÈ̤Ë0¡¥06¤¯¤é¤¤¤È¤µ¤ì¤ë(2)¡¥

çÁÂÓÀÅÌ®¤Ë¤ª¤±¤ë·ì±Õ¥¬¥¹¤Ï°ìÈ̤ËÂÛÈפε¡Ç½¤òÈ¿±Ç¤¹¤ë¡¥çÁÂÓÀÅÌ®·ì¤Î»ÀÁÇʬ°µ(PO2)¤ÏÊìÂΦư̮·ì¤ËÈæ¤Ù¤Æ¤«¤Ê¤êÄ㤤ÃͤǤ¢¤ê¡¤ÊìÂΦÂÛÈפÎÀÅÌ®·ì¤ËÈæ¤Ù¤Æ¤âÄ㤤¡¥¤³¤ì¤ÏÂÛÈפˤª¤±¤ë»Àº÷¤Î³È»¶Ê¿¹Õ¤¬´°Á´¤Ë¤Ï¹Ô¤ï¤ì¤Ê¤¤¤¿¤á¤Ç¤¢¤ë¡¥CO2¤Ç¤Ï¤½¤ì¤¬¤Û¤Ü´°Á´¤Ë¤Ê¤µ¤ì¤Æ¤¤¤ë¡¥¤¤¤ï¤æ¤ëÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤ª¤¤¤Æ¤ÏçÁÂÓÀÅÌ®·ì¤ÎPO2¤ÎÄã²¼¤¬À¸¤¸¡¤¤µ¤é¤Ë°­²½¤¹¤ë¤ÈPCO2¤¬¾å¾º¤·¤Æ¤¯¤ë¡¥çÁÂÓÀÅÌ®·ì¤ÎPO2¤ÎÄã²¼¤Ï¡¤ÂÛÈפˤª¤±¤ë¥¬¥¹³È»¶Ç½¤ÎÄã²¼¤äÊìÂΦÂÛÈפÎÞõήÄã²¼¡¤ÊìÂΤÎÉÏ·ì¤äÄã»ÀÁǤʤɡ¤¤µ¤Þ¤¶¤Þ¤Î¸¶°ø¤Ë¤è¤Ã¤ÆÀ¸¤¸¤¦¤ë¡¥

°ìÊý¡¤çÁÂÓ¶ÐÌ®¤Ë¤ª¤±¤ë·ì±Õ¥¬¥¹¤ÈpH¤ÏÂÛ»ù¾õÂ֤ξÀܤÎÈ¿±Ç¤Ç¤¢¤ë¡¥PO2¤ÎÄã²¼¤ÏÂÛ»ùÁÈ¿¥¤Ë¤ª¤±¤ëÄã»ÀÁǾÉ(hypoxia)¤ò°ÕÌ£¤¹¤ë¡¥Æ°ÀÅ·ì¤È¤â¬Äê²Äǽ¤Î¾ì¹ç¤Ï¡¤ ¤è¤êÂÛ»ù¾õÂÖ¤òÈ¿±Ç¤·¤Æ¤¤¤ëçÁÂÓÆ°Ì®·ì¤Ç¤Îɾ²Á¤¬¿ä¾©¤µ¤ì¤ë¡¥¤¿¤È¤¨¤ÐçÁÂÓæ½Ð¤¬µ¯¤­¤¿¤È¤­¤Î¤è¤¦¤Ê¶Ëü¤Ê¾ì¹ç¡¤ÂÛ»ù¤ª¤è¤Ó¾¡ÂÓÆ°Ì®·ì¤Ë½Å¾É¤Î¥¢¥·¥É¡¼¥·¥¹¤¬À¸¤¸¤Æ¤¤¤Æ¤âçÁÂÓÀÅÌ®·ì¥¬¥¹Ãͤ¬Àµ¾ï¤Ê¤³¤È¤â¤¢¤ê¤¦¤ë¤«¤é¤Ç¤¢¤ë(3)¡¥

¤·¤«¤·PUBS¤Ë¤ª¤¤¤Æ¤Ï¡¤¾¡ÂÓÀÅÌ®·ì¤Î¤Û¤¦¤òºÎ¼è¤·¤Æ·ì±Õ¥¬¥¹¤ª¤è¤ÓpH¤Îɾ²Á¤ò¹Ô¤¦¤³¤È¤¬°ìÈÌŪ¤Ç¤¢¤ë¡¥ÍýÏÀŪ¤Ë¤ÏçÁÂÓÆ°Ì®¤«¤é¤Î·ì±Õ¤¬ÂÛ»ù¤Ë´Ø¤¹¤ëºÇ¤â¿¤¯¤Î¾ðÊó¤ò´Þ¤ó¤Ç¤¤¤ë¤¬¡¤çÁÂÓÆ°Ì®¤ÎÀü»É¤Ï¤«¤Ê¤êÆñ°×ÅÙ¤¬¹â¤¯¡¤¤Þ¤¿Àü»É¤Ë¤è¤Ã¤ÆÀ¸¤¸¤ëÂÛ»ù½ùÌ®¤Î¥ê¥¹¥¯¤¬²¿Çܤâ¹â¤¤¤¿¤á¤Ç¤¢¤ë¡¥¤â¤·ç¯ÂÓÀÅÌ®·ì¤¬°Û¾ï¤ò¼¨¤¹¤Ê¤é¤ÐçÁÂÓÆ°Ì®·ì¤Ë¤ª¤¤¤Æ¤â°Û¾ï¤È¿ä¬¤¹¤ë¤³¤È¤Ï½½Ê¬²Äǽ¤Ç¤¢¤ë¡¥

b. ÂÛ»ù·ì±Õ¤ÎÆÃÀ­

·ì±Õ¥¬¥¹¤ÈpH¤Î¬Äê¤È¥Ç¡¼¥¿¤Î²ò¼á¤ËºÝ¤·¤Æ¡¤À®¿Í¤ÈÂÛ»ù¤Î¾ò·ï¤Î°ã¤¤¤ò¹Íθ¤¹¤ëɬÍפ¬¤¢¤ë¡¥¤Ò¤È¤Ä¤Ë¤Ï¡¤ÂÛ»ù¤ÎPO2¤¬À®¿Í¤ËÈæ¤Ù¤Æ¤­¤ï¤á¤ÆÄ㤯¡¤¤½¤Îº¹¤òÍøÍѤ·¤¿³È»¶¤Ë¤è¤Ã¤ÆÂÛÈפǻÀÁǤΰÜÆ°¤¬¤Ê¤µ¤ì¤Æ¤¤¤ë¤³¤È¤Ç¤¢¤ë¡¥ÂÛ»ù¥Ø¥â¥°¥í¥Ó¥ó(hemoglobin F; HbF)¤ÎÆÃħ¤È¤·¤Æ»ÀÁDzòÎ¥¶ÊÀþ¤¬º¸Êý¤Ë°ÜÆ°¤·¤Æ»ÀÁDZ¿ÈÂǽ¤¬ÁýÂ礷¤Æ¤ª¤ê¡¤¤«¤Ä»ÀÁÇ¿ÆÏÂÀ­¤¬¹â¤¤¤¿¤á¡¤PO2¤ÎÄ㤵¤¬ÁÈ¿¥¤Ø¤Î»ÀÁDZ¿ÈÂǽ¤ÎľÀܤÎ˸¤²¤È¤Ï¤Ê¤Ã¤Æ¤¤¤Ê¤¤¡¥

2¤Ä¤á¤Ï·ì±Õ¥¬¥¹Â¬Äê¤Ë¤ª¤±¤ë²¹ÅÙÊäÀµ¤ÎÌäÂê¤Ç¤¢¤ë¡¥ÂÛ»ù´Ä¶­¤Ç¤¢¤ë»ÒµÜÆâ¤ÏÊìÂΤο¼ÉôÂβ¹¤Ë¶á¤¤39ÅÙÁ°¸å¤Ë¤¢¤ë¡¥°ìÈ̤˻ÈÍѤµ¤ì¤Æ¤¤¤ë·ì±Õ¥¬¥¹¼«Æ°Â¬ÄêÁõÃ֤ǤÏɸ½àÂβ¹¤Ç¤¢¤ë37ÅÙ¤òÁ°Äó¤Ë·×»»¤µ¤ì¤ë¤¿¤á¡¤¼ÂºÝ¤ÎÂÛ»ù¤Î´Ä¶­²¹¤Ç¤ÎÃͤÈÈæ¤Ù¤ë¤ÈpH, PO2, PCO2¤È¤âÄ㤯ɽ¤µ¤ì¤ë¤³¤È¤Ë¤Ê¤ë(4)¡¥ÂÛ»ùɾ²Á¤Î¼ÂºÝ¤Î¾ì¤Ç¤Ï¡¤ÊäÀµ¤·¤Ê¤¤ÃͤÇÅý°ì¤·¤Æ¸¡Æ¤¤¹¤ë¤³¤È¤¬Â¿¤¤¤è¤¦¤Ç¤¢¤ë¡¥

3¤Ä¤á¤ÏHbF¤ÎÌäÂê¤Ç¤¢¤ë¡¥»ÀÁÇ´ÞÎÌ¡Êoxygen content¡Ë¤ä»ÀÁÇË°ÏÂÅÙ¡Êoxygen saturation¡Ë¤Ê¤É¤Î¬ÄêÃͤϷì±Õ¥µ¥ó¥×¥ë¤Î¥Ø¥â¥°¥í¥Ó¥óÇ»Å٤˰͸¤¹¤ë¡¥Ä̾»À²½¥Ø¥â¥°¥í¥Ó¥ó¤òcooximetry¤ÇľÀܬÄꤷ¡¤·×»»¤Ç¤³¤ì¤é¤ÎÃͤò»»½Ð¤¹¤ë¤³¤È¤Ë¤Ê¤ë¡¥ ¤·¤«¤·¡¤ÂÛ»ù¡¦¿·À¸»ù¤Î¾ì¹ç¤Ï¥Ø¥â¥°¥í¥Ó¥óÃæ¤ÎHbF¤Î³ä¹ç¤¬¹â¤¤¤¿¤á¡¤»ÀÁÇ´ÞÎÌ¡¤»ÀÁÇË°ÏÂÅ٤Ȥ⸶Íý¾åÊäÀµ¤¬É¬ÍפȤʤ롥 ¤·¤«¤·¡¤HbF¤Î³ä¹ç¤ÏÇ¥¿±½µ¿ô¤Ë¤è¤Ã¤Æ¤âÊѤï¤ë¤¿¤á¡¤¼ÂºÝ¤Î¤È¤³¤íÎ×¾²¤Î¾ì¤Ç¤Ï¡¤·×¬µ¡³£¤ËÆ⢤µ¤ì¤¿À®¿ÍÍÑ¥×¥í¥°¥é¥à¤Ç·×»»¤µ¤ì¤¿Ãͤò¤½¤Î¤Þ¤Þ»ÈÍѤ¹¤ë¤³¤È¤¬Â¿¤¤¡¥

¡¡

 2. PUBS¤Î¼ÂºÝ

PUBS¤Ï¡¤Ç¥¿±Ãæ¤ËÊìÂÎÊ¢Êɤò²ð¤·¤ÆĶ²»ÇÈ¥¬¥¤¥É²¼¤ËçÁÂÓÀÅÌ®¤òÀü»É¤·¤ÆºÎ·ì¤¹¤ë¼êµ»¤ò»Ø¤¹¡¥¤¯¤ï¤·¤¤¼êµ»¤Î¼ÂºÝ¤Ï¾¹Æ(5)(6)¤Ë¾ù¤ê¡¤ ¤³¤³¤Ç¤Ï¤½¤ÎŬ±þ¤È´í¸±À­¤Ë¾ÇÅÀ¤ò¤ª¤¤¤ÆÀâÌÀ¤¹¤ë¡¥

a. PUBS¤Î°ìÈÌŪŬ±þ

PUBS¤Î¼ç¤ÊŬ±þ¤Ï¡¤ÂÛ»ù°Û¾ï¤Ë¤ª¤±¤ëÀ÷¿§Âο×®¿ÇÃǤÈÂÛ»ùÉÏ·ì¤òµ¿¤Ã¤¿¤È¤­¤ÎËö¾¿·ìɾ²Á¤Ç¤¢¤ê¡¤¤µ¤é¤ËÂÛ»ù´¶À÷¡ÊÉ÷¿¾¡¤¥µ¥¤¥È¥á¥¬¥í¥¦¥¤¥ë¥¹¡¤¥Ñ¥ë¥Ü¥¦¥¤¥ë¥¹´¶À÷¾É¤Ê¤É¡Ë¤Î½ÐÀ¸Á°¿ÇÃǤä·ì±Õ¥¬¥¹¡¤»À±ö´ðÊ¿¹Õ¤Ê¤É¤Ë¤è¤ëÂÛ»ùwell-beingɾ²Á¤Ê¤É¤â¹Ô¤ï¤ì¤ë¡¥

IUGR¤ËÂФ¹¤ëPUBS¤Ë¤Ï¡¤Â礭¤¯Ê¬¤±¤ë¤È°Ê²¼¤Î3¤Ä¤ÎÌÜŪ¤¬Â¸ºß¤¹¤ë¡¥¤Ò¤È¤Ä¤ÏIUGR¤Î´ÕÊÌ¿ÇÃÇ¡¤¤¹¤Ê¤ï¤Á¸¶°ø¤Î¸¡º÷¤Ë¤¢¤ê¡¤¶ñÂÎŪ¤Ë¤ÏÂÛ»ùÀ÷¿§ÂÎʬÀϤª¤è¤ÓÂÛÆâ´¶À÷¤Î̵ͭ¤Î¥Á¥§¥Ã¥¯¤Ç¤¢¤ë¡¥À÷¿§Âθ¡ºº¤ÏÂÛ»ù¤Î¤É¤ÎÉôʬ¤ÎÁÈ¿¥¤«¤é¤Ç¤â¤Ç¤­¤ë¤¬¡¤ÂÛ»ù·ì¤Î¤ß¤¬¤¹¤Ù¤Æ¤Î²ÄǽÀ­¤ËÂФ·¤ÆÂбþ¤Ç¤­¤ë¥¢¥×¥í¡¼¥Á¤È¤¤¤¨¤ë¡¥¤Þ¤¿¡¤ÂÛ»ù¥ê¥ó¥Ñµå¤ò»È¤Ã¤¿À÷¿§Âο×®ʬÀϤǤÏ2¡Á3Æü¤Ç·ë²Ì¤¬½Ð¤ëÍøÅÀ¤¬¤¢¤ê¡¤ 2¡Á4½µ´Ö¤òɬÍפȤ¹¤ëÍÓ¿åÀü»É¤ËÂ礭¤¯¾¡¤ë¡¥

2¤Ä¤á¤Ï¡¤ÂÛ»ù¤Î·ì±Õ¥¬¥¹¡¤pH¤Î¬Äê¤Ë¤è¤Ã¤ÆÄã»ÀÁÇ·ì¾É¡¤¥¢¥·¥É¡¼¥·¥¹¤òɾ²Á¤·¡¤»ù¤ÎÊڽФΥ¿¥¤¥ß¥ó¥°¤ÈÊýË¡¤ò·èÄꤹ¤ëÌÜŪ¤Ç¤¢¤ë¡¥ 3¤Ä¤á¤Ï¡¤ÂÛ»ù¼£ÎŤΤ¿¤á¤ÎÊìÂιâÇ»ÅÙ»ÀÁÇÅêÍ¿¤ÎŬ±þ¤È¸ú²Ì¤Î̵ͭ¤ò¤ß¤ëÌÜŪ¤Ç¤¢¤ë¡¥¤³¤ì¤ËÉÕ¤±²Ã¤¨¤ì¤Ð¡¤¸½ºß¤Ç¤Ï¿ÇÃǤ伣ÎŤòÌÜŪ¤È¤·¤¿°ìÈ̤ÎPUBS¤Ë¤ª¤¤¤Æ¤â¡¤·ì±Õ¥¬¥¹¤ª¤è¤ÓpH¤Î·×¬¤âƱ»þ¤Ë¤Ê¤µ¤ì¤ë¤Î¤¬Ä̾ï¤Ç¤¢¤í¤¦¡¥PUBS¼«ÂΤˤè¤ëÂÛ»ù¤Ø¤Î¿¯½±ÅÙ¤òɾ²Á¤¹¤ë¤¿¤á¤Ç¤¢¤ë¡¥

b. PUBS¤ÎÁàºî¤Ëȼ¤¦´í¸±À­

PUBS¤ÏÍÓ¿åÀü»É¤Ê¤É¤Î¾¤Î¿¯½±Åª¸¡ºº¤ÈƱÅù¤Î´í¸±À­¤ò¤â¤Ä¡¥Êó¹ð¤µ¤ì¤Æ¤¤¤ë¼ç¤Ê¹çÊ»¾É¤Ë¤ÏÂÛ»ù½ùÌ®¡¤Á°´üÇ˿塤»ÒµÜÆâ´¶À÷¡¤ÁỺ¡¤½Ð·ì¤Ê¤É¤¬¤¢¤ë¡¥ÂÛ»ù½ùÌ®¤ÏÁ´ÂΤÎ10%ÄøÅ٤˴ѻ¡¤µ¤ì¤ë¤¬¡¤¤Û¤È¤ó¤É¤¬°ì»þŪ¤Ê¤â¤Î¤Ç¼«Á³¤Ë²óÉü¤¹¤ë¤³¤È¤¬Â¿¤¤¡¥

PUBS¤Ë´ØÏ¢¤·¤¿»ÒµÜÆâÂÛ»ù»àË´(IUFD)¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¤¬¡¤¤½¤Î´í¸±À­¤ÏÂоݤȤ¹¤ëÂÛ»ù½¸ÃĤˤè¤Ã¤ÆÂ礭¤¯Åµ¤Ê¤ë¡¥´ñ·Á¤¬¤¢¤êÀ÷¿§Âΰ۾ï¤ò¤â¤ÄÂÛ»ù¤Ç¤Ï´í¸±À­¤Ï¹â¤¯¤Ê¤ë¡¥Daffos (7)¤Î1,320²ó¤ÎPUBS¤Î·Ð¸³¤Ç¤Ï¡¤21Îã¤ÎIUFD¤¬¤¢¤ê¡¤1.6%¤Î´í'·ðΨ¤Ç¤¢¤Ã¤¿¡¥Weiner¤é(8)¤ÎÊó¹ð¤Ç¤Ï¡¤594²ó¤Î»Ü¹Ô¤ÇIUFD¤Ï0.8%¤Ëǧ¤á¤é¤ì¤¿¡¥Ãø¼Ô¤é¤Î»ÜÀß(ÅìËÌÂç³Ø°å³ØÉô»ºÉؿͲʡˤˤª¤¤¤Æ¤Ï¡¤2001ǯ4·î¤Þ¤Ç¤Î701²ó¤ÎPUBS»Ü¹Ô¤Ç6Îã¤ÎIUFD¤ò·Ð¸³¤·¤¿(0.9%)¡¥PUBS¤Î´í¸±À­¤ÏŬ±þ¤È½Ñ¼Ô¤Îµ»Î̤Îξ¼Ô¤Ë´ØÏ¢¤¹¤ë¤¬¡¤IUFD¤ÎÉÑÅ٤ϤۤÜ1%Á°¸å¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡¥

¡¡

 3. PUBS¤Ë¤è¤ëÂÛ»ùwell-beingɾ²Á

a. Á·ÂÓÀÅÌ®¤Ë¤ª¤±¤ë·ì±Õ¥¬¥¹¡¤pH¤Î´ð½àÃÍ

çÁÂÓÀÅÌ®·ì¤Î·ì±Õ¥¬¥¹¡¤pHÃͤÏÇ¥¿±½µ¿ô¤È¤È¤â¤ËÊѲ½¤¹¤ë¤Î¤Ç¡¤¼ÂºÝ¤Î¬ÄêÃͤòɾ²Á¤¹¤ë¤Ë¤¢¤¿¤Ã¤Æ¤ÏÇ¥¿±½µ¿ô¤ò¹Íθ¤ËÆþ¤ì¤ëɬÍפ¬¤¢¤ë¡¥PUBS¤Î¥Ç¡¼¥¿¤Ë¤è¤ë´ð½àÃͤˤĤ¤¤Æ¤Ï¤¤¤¯¤Ä¤«¤ÎÊó¹ð¤¬¤¢¤ë(1)(9)¡¥¿Þ73¡Á75¤ËÃø¼Ô¤é¤¬Êó¹ð¤·¤¿çÁÂÓÀÅÌ®·ì¤Î·ì±Õ¥¬¥¹¡¤pH¤ÎÇ¥¿±½µ¿ô¤Ë¤ª¤±¤ë´ð½àÃÍ¡Ê95¡ó¿®Íê¶è´Ö¡Ë¤ò¼¨¤¹(10)¡¥

°ìÈ̤ˡ¤Ç¥¿±½µ¿ô¤È¤È¤â¤ËçÁÂÓÀÅÌ®·ìPO2¤ÈpH¤ÏľÀþŪ¤ËÄã²¼¤·¡¤PCO2¤ÏľÀþŪ¤ËÁý²Ã¤¹¤ë¡¥PO2¤ÏÇ¥¿±½µ¿ô¤È¤È¤â¤ËÄã²¼¤¹¤ë¤¬¡¤¥Ø¥â¥°¥í¥Ó¥ó¡¤ÀÖ·ìµå¿ô¤ÎÁý²Ã¤Ë¤è¤Ã¤ÆÁ껦¤µ¤ì¡¤ÂÛ»ù·ìÃæ¤Î»ÀÁÇ´ÞÎ̤ÏÇ¥¿±Ãæ¤ËÂ礭¤ÊÊѲ½¤Ï¤Ê¤¤¡¥çÁÂÓÀÅÌ®·ì¤ÎÊ¿¶Ñ»ÀÁÇ´ÞÎ̤Ï6.7¡Þ0¡¥6mmol/L¤È¤Ê¤ë(11)¡¥

b. IUGR¤ËÂФ¹¤ëPUBS¤Î»î¤ß

IUGR¤Ï»ù¤Îͽ¸å¤ËÂ礭¤¯±Æ¶Á¤¹¤ë¤¿¤á¡¤°ÍÁ³¤È¤·¤Æ¼þ»º´ü°åÎŤÎÂ礭¤ÊÌäÂê¤Î¤Ò¤È¤Ä¤Ç¤¢¤ë¡¥Ä̾ï¤ÏĶ²»ÇÈÃÇÁØË¡¤Ë¤è¤ë»ùÂνŤοäÄê¤È¤È¤â¤Ë¡¤È󿯽±ÅªÊýË¡¤Ë¤è¤ëÂÛ»ùwell-beillgɾ²Á¤¬¹Ô¤ï¤ì¤Æ¤¤¤ë¡¥ ¤·¤«¤·¡¤½¾Íè¤ÎÂÛ»ù¿´Çï¿ô(FHR)¥â¥Ë¥¿¥ê¥ó¥°¤Ê¤É¤ÎÊýË¡¤ÏÂÛ»ù¤Îasphyxia¤ÎͽÃΤ˸³¦¤¬¤¢¤ê¡¤ ¤·¤Ð¤·¤ÐÊڽлþ´ü¤Î·èÄê¤Ë̤¦¤³¤È¤¬¤¢¤ë¡¥

PUBS¤Ë¤è¤ëçÁÂӷ쥬¥¹¤Î¬Äê¤Ï²¿¤è¤ê¤âÀµ³Î¤ÊÂÛ»ùɾ²Á¤À¤È¤¤¤¦ÍøÅÀ¤¬¤¢¤ê¡¤ ¤³¤¦¤¤¤Ã¤¿¥Ï¥¤¥ê¥¹¥¯ÂÛ»ù¤«¤éľÀܾðÊó¤òÆÀ¤é¤ì¤ë¤Î¤ÏÌ¥ÎÏŪ¤Ç¤¢¤ë¡¥¤½¤ì¤Þ¤Ç¤Ë¤â½ÐÀ¸»þ¤ÎçÁÂÓ·ìʬÀϤˤè¤Ã¤Æ¡¤IUGR»ù¤¬ÆÃħŪ¤Ê·ì±Õ¥¬¥¹¡¤Âå¼Õ¡¤Ëö¾¿·ì½ê¸«¤ò¼¨¤¹¤³¤È¤Ï¤ï¤«¤Ã¤Æ¤¤¤¿¡¥1980ǯÂåȾ¤Ð¤ËPUBS¤¬¼ÂÍѲ½¤µ¤ì¤ë¤È¡¤IUGR¤ËÂФ·¤Æ¤â¤¹¤°¤Ë»î¤ß¤é¤ì¤Æ¤¤¤ë(12)(13)¡¥1990ǯÁ°¸å¤Ë¤ÏIUGR¤ÎŬ±þ¤¬¤µ¤é¤Ë³ÈÂ礷¡¤¿¯½±Åª¸¡ºº¤Ç¤¢¤ëPUBS¤¬ÂÛ»ù´ÉÍý¤ËÍ­ÍѤǤ¢¤ë¤³¤È¤ò¼¨º¶¤¹¤ëÊó¹ð¤¬Á꼡¤¤¤À(9)(14-16)¡¥¤â¤È¤â¤ÈPUBS¤Ï¼ç¤ËÀ÷¿§ÂΤο×®¸¡ºº¤È´¶À÷¾É¤Î¥¹¥¯¥ê¡¼¥Ë¥ó¥°¤òÌÜŪ¤È¤·¤Æ»Ï¤á¤é¤ì¤¿¤¬¡¤»À±ö´ðÊ¿¹Õ¤Î¥Ç¡¼¥¿¤¬ÂÛ»ùÊڽФλþ´ü¤ÈÊýË¡¤ò·èÄꤹ¤ë¤Î¤ËÈó¾ï¤ËÍ­ÍѤȹͤ¨¤é¤ì¤¿¡¥

c. IUGR»ù¤Î·ì±Õ¥¬¥¹¡¤pH½ê¸«

IUGR»ù¤Î°ìÉô¤ËÄã»ÀÁÇ·ì¾É¡¤¹âú»À¥¬¥¹·ì¾É(hypercapnia)¡¤¥¢¥·¥É¡¼¥·¥¹¤¬Ç§¤á¤é¤ì¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë(9)¡¥¤³¤ì¤é¤Î·ì±Õ¥¬¥¹¤Î°Û¾ïÃͤò¼¨¤¹ÂÛ»ù¤Ë¤ª¤¤¤Æ¤Ï¡¤»ÒµÜÆâ¤Ç¤¹¤Ç¤ËÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤ëasphyxia¤òÄ褷¤Æ¤¤¤ë¤È¹Í¤¨¤é¤ì¤ë¡¥Àµ¾ïÈÏ°ÏÆâ¤Ë¤È¤É¤Þ¤ëÎã¤â¿¤¤¤Î¤Ï¡¤È¯°éÃÙ±ä¤Î¸¶°ø¤¬ÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤ëÄã»ÀÁÇ¡¤Äã±ÉÍܤÀ¤±¤Ç¤Ï¤Ê¤¯Â¿Íͤʤâ¤Î¤ò´Þ¤à¤«¤é¤À¤í¤¦¡¥

¿Þ76¤ËÃø¼Ô¤é¤Î»ÜÀߤǤΥǡ¼¥¿(10)¤ò¼¨¤¹¡¥½Å¾ÉÇ¥¿±¹â·ì°µ¾ÉÇ¥ÉؤËǧ¤á¤é¤ì¤¿IUGR»ù¤Ë»Ü¹Ô¤·¤¿PUBS¤Ë¤è¤ëçÁÂÓÀÅÌ®·ì±Õ¥¬¥¹¤ª¤è¤ÓpH¤Î·ë²Ì¤Ç¤¢¤ë¡¥È¯°éÃÙ±ä¤Î¸¶°ø¤Î¤Û¤È¤ó¤É¤¬ÂÛ¿÷µ¡Ç½ÉÔÁ´¤È¹Í¤¨¤é¤ì¡¤Â¿¤¯¤ÎÎã¤ÇPO2¡¤PCO2¡¤pH¤¬´ð½àÃͤ«¤é³°¤ì¤¿Ãͤò¼¨¤·¤Æ¤¤¤ë¡¥ÃíÌܤ¹¤Ù¤­¤ÏÂÛ»ù¤Îͽ¸å¤È¤Î´ØÏ¢¤Ç¤¢¤ê¡¤36ÎãÃæ6Îã¤ÎÂÛ»ù¤¬½ÐÀ¸Á°¤¢¤ë¤¤¤Ï½ÐÀ¸¸å¤Ë»àË´¤·¤Æ¤¤¤ë¤¬¡¤¤½¤Î¤Û¤È¤ó¤É¤¬´ð½àÃͤ«¤éÂ礭¤¯³°¤ì¤¿Ãͤò¼¨¤·¤¿¡¥ÂÛ»ù¤ÎÀ¸Â¸Îã¤Èͽ¸åÉÔÎÉÎã¤Ëʬ¤±¤ÆÈæ³Ó¤·¤¿¤È¤³¤í¡¤PO2¡¤PCO2¡¤pH¤ª¤è¤Ó½ÐÀ¸½µ¿ô¤ËÍ­°Õ¤Îº¹¤òǧ¤á¤¿(10)¡¥¤¹¤Ê¤ï¤ÁÂÛ»ù¤Îͽ¸å¤Ï¡¤PUBS¤Ë¤è¤ëçÁÂÓÀÅÌ®·ì±Õ¥¬¥¹Ãͤª¤è¤Ó½ÐÀ¸½µ¿ô¤Î¤Õ¤¿¤Ä¤ËÂ礭¤¯°Í¸¤·¤Æ¤¤¤ë¤³¤È¤¬¤ï¤«¤ë¡¥

½Å¾ÉIUGR¤Ç¤ÏÄã»Àº÷·ì¾É¤Î¤Û¤«¤Ë¥¢¥·¥É¡¼¥·¥¹¤ò¼¨¤¹¤¬¡¤¤³¤ì¤Ï°ìÈÌŪ¤ËÂå¼ÕÀ­¤Þ¤¿¤Ïº®¹çÀ­¥¢¥·¥É¡¼¥·¥¹¤Ç¤¢¤ë¡¥ÂÛ»ù¥¢¥·¥É¡¼¥·¥¹¤Ï¸¶°ø¤¬À÷¿§Âΰ۾ÀèÅ·´¶À÷¡¤ÂÛ¿÷µ¡Ç½ÉÔÁ´¤Î¤¤¤º¤ì¤Î¾ì¹ç¤Ç¤¢¤Ã¤Æ¤âµ¯¤³¤ê¤¦¤ë(15)¡¥À÷¿§Âΰ۾ï¤òȼ¤ï¤Ê¤¤IUGR¤Î¤ª¤è¤½È¾Ê¬¤Ë¡¤Ä¶²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬¤ÇÂÛÈ×·ì´ÉÄñ¹³¤Î¾å¾º¤òǧ¤á¤ë¡¥ÀèÅ·´¶À÷¤Ë¤è¤ëIUGR¤Ë¤ª¤¤¤Æ¤âÂÛÈ×·ì´ÉÄñ¹³¤Î¾å¾º¤òǧ¤á¤ë¤¬¡¤ ¤³¤ì¤ÏÂÛÈ×´¶À÷¤Ë¤è¤ë±ê¾É¤Î¤¿¤á¤È¹Í¤¨¤é¤ì¤ë¡¥

PCO2¤Î¾å¾º¤Ï¡¤ÂÛÈפǤΥ¬¥¹¸ò´¹¤Î¸º¾¯¤ò°ÕÌ£¤¹¤ë¡¥çÁÂÓÀÅÌ®·ì¤Ë¤ª¤±¤ë·ÚÅÙ¤ÎÄã»ÀÁÇ·ì¾É¤Ç¤Ï¹âú»À¥¬¥¹·ì¾É¤ä¥¢¥·¥É¡¼¥·¥¹¤òǧ¤á¤Ê¤¤¤¬¡¤¤³¤Î¾ì¹ç¤Ç¤âçÁÂÓÆ°Ì®·ì¤Ë¤ª¤¤¤Æ¤Ï¡¤Äã»ÀÁÇ·ì¾É¤Î½é´ü¤«¤éPO2¤Î¾å¾º¤ÈpH¤ÎÄã²¼¤¬Ç§¤á¤é¤ì¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤ë(9)¡¥¤³¤¦¤¤¤Ã¤¿·ÚÅÙ¤ÎÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤ª¤¤¤Æ¤Ï¡¤çÁÂÓÀÅÌ®·ì¤ËÃßÀѤ·¤¿CO2¤ÏÂÛÈפò1²óÄ̲᤹¤ë¤À¤±¤Ç½üµî¤µ¤ì¡¤çÁÂÓÀÅÌ®·ì¤ÎPCO2¤ÏÀµ¾ïÈÏ°ÏÆâ¤Ë¤Ê¤ë¡¥

È¿ÂФ˷ÚÅÙ¤ÎÄã»ÀÁÇ·ì¾É¤È¹âÆý»À·ì¾É¤Î¸ºß¤ÏÂÛÈ×µ¡Ç½ÉÔÁ´¤ÎÁá´ü¤Îħ¸õ¤Ç¤¢¤ë¡¥ÂÛÈ×µ¡Ç½ÉÔÁ´¤¬½Å¾É¤Ë¤Ê¤ë¤È¡¤CO2»ºÀ¸¤¬ÂÛÈפǤνüµî¤Î®ÅÙ¤ò¾å²ó¤ë¤è¤¦¤Ë¤Ê¤ë¤Î¤Ç¡¤çÁÂÓÀÅÌ®·ì¤Ë¤ª¤±¤ë¹âú»À¥¬¥¹·ì¾É¤È¥¢¥·¥É¡¼¥·¥¹¤Î¸ºß¤ÏÂÛÈ×µ¡Ç½ÉÔÁ´¤¬¤«¤Ê¤ê¿Ê¤ó¤À¾õÂ֤Ǥ¢¤ë¤³¤È¤ò°ÕÌ£¤¹¤ë¡¥¤¹¤Ê¤ï¤Á¡¤ÂÛÈ×µ¡Ç½ÉÔÁ´¤Î¿ÇÃǤϡ¤çÁÂÓÀÅÌ®·ì¤Ë¤ª¤±¤ëÄã»ÀÁÇ·ì¾É¤È¹âÆý»À·ì¾É¡¤¤¢¤ë¤¤¤ÏçÁÂÓÆ°Ì®·ì¤Ë¤ª¤±¤ë¹âú»À¥¬¥¹·ì¾É¤È¥¢¥·¥É¡¼¥·¥¹¤Î¸ºß¤¬¥Ý¥¤¥ó¥È¤È¤Ê¤ë¡¥

¡¡

d. IUGR»ù¤ÎÆý»ÀÃͤȥ°¥ë¥³¡¼¥¹ÃÍ

Àµ¾ïÇ¥¿±¤Ë¤ª¤±¤ëÂÛ»ù·ìÃæ¤ÎÆý»ÀÃͤϡ¤çÁÂÓÀÅÌ®¤Ç0.99¡Þ0.32m'mol/L¡¤çÁÂÓÆ°Ì®¤Ç0.92¡Þ0.21mmol/L¤Ç¤¢¤ë(9)¡¥¤³¤ì¤é¤ÎÃͤÏÇ¥¿±½µ¿ô¤Ë¤«¤«¤ï¤é¤º¤Ð¤Ý°ìÄê¤Ç¤¢¤ê¡¤ÊìÂηìÃæ¤ÎÆý»ÀÃͤËÁê´Ø¤¹¤ë¡¥ÂÛ»ùÄã»ÀÁǾɤäÂÛÈ×·ì´ÉÄñ¹³¤Î¾å¾º¤¬¤ª¤³¤ë¤ÈÂÛ»ù·ìÃæÆý»ÀÃͤ¬Áý²Ã¤·¤Æ¤¯¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤ë(17)¡¥FHR¥â¥Ë¥¿¥ê¥ó¥°¤Î½ê¸«¤¬°­²½¤¹¤ëÁ°¤ËÂÛ»ù·ìÃæÆý½ÙÃͤ¬¾å¾º¤¹¤ë¤È¤¤¤¦Êó¹ð¤â¸ºß¤¹¤ë(18)¡¥

çÁÂÓÀÅÌ®·ì¤Î¥°¥ë¥³¡¼¥¹ÃͤÏÊìÂηì¤Î¤½¤ì¤È¤è¤¯Áê´Ø¤·¡¤ÊìÂηì¤Î¤ª¤è¤½70¡Á80¡ó¤ÎÃͤò¼¨¤¹¡¥ ¤³¤ì¤ÏÂÛ»ù¤Î¥°¥ë¥³¡¼¥¹¤¬¤Û¤È¤ó¤ÉÊìÂΤ«¤éͳÍ褷¡¤ÂÛÈפǤÎÍ¢Á÷¤¬Ç»ÅÙ¸ûÇۤ˰͸¤·¤¿Â¥¿Ê³È»¶¤Ë¤è¤ë¤¿¤á¤Ç¤¢¤ë¡¥IUCR»ù¤¬½ÐÀ¸Ä¾¸å¤«¤éÄã·ìÅü¤ò¼¨¤¹¤³¤È¤Ï¤è¤¯ÃΤé¤ì¤Æ¤¤¤ë¤¬¡¤¼Â¤Ï»ÒµÜÆâ¤Ç¤¹¤Ç¤ËÄã·ìÅü¤¬Â¸ºß¤·¤Æ¤¤¤ë¤³¤È¤¬PUBS¥Ç¡¼¥¿¤«¤é¤ï¤«¤Ã¤¿(19)¡¥¤³¤ì¤Ï¡¤IUGR»ù¤Ë¤ª¤±¤ë¥°¥ê¥³¡¼¥²¥ó¤ÎÃù¢¤¬¤­¤ï¤á¤ÆÄ㤤¤¿¤á¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡¥¥°¥ë¥³¡¼¥¹ÃͤÏÄã»ÀÁǾɤÎÄøÅÙ¤ÈÁê´Ø¤·¡¤ÂÛÆâ¤ÇÄã·ìÅü¤ò¶¯¤¯¼¨¤¹¤Û¤ÉÂÛ»ù¤Îͽ¸å¤¬°­¤¤¡Ê̤ȯɽ¥Ç¡¼¥¿¡Ë ¡Ê¿Þ77)¡¥Æý»À¤ä¥°¥ë¥³¡¼¥¹¤¬ÂÛ»ùɾ²Á¤ËľÀÜÍѤ¤¤é¤ì¤ë¤³¤È¤Ï¿¤¯¤Ê¤¤¤¬¡¤¤â¤·¤³¤ì¤é¤ÎÃͤ¬·ÚÅÙÄã»ÀÁǾɤαÔÉҤʥޡ¼¥«¡¼¤Ç¤¢¤ì¤Ð¡¤ÊìÂλÀÁÇÎÅË¡¤ÎŬ±þ¤ò·è¤á¤ë¤Î¤ËÍ­ÍѤ«¤â¤·¤ì¤Ê¤¤¡¥

ÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤ëȯ°éÃÙ±ä¤Î¾ì¹ç¡¤¤½¤ì°Ê³°¤ÎÂå¼Õ°Û¾ï¤â¸ºß¤¹¤ë¡¥ ¥¤¥ó¥¹¥ê¥ó¡¤¥°¥ë¥³¡¼¥¹Ç»ÅÙ¤¬¸º¾¯¤¹¤ë¤¿¤á·ìÃæ¥È¥ê¥°¥ê¥»¥ê¥ÉÃͤ¬¾å¾º¤¹¤ë(20)¡¥ ¥È¥ê¥°¥ê¥»¥ê¥ÉÃͤξ徺¤Ï¡¤»éËäλÀ²½¤Î¾ã³²¤¢¤ë¤¤¤Ï»éËÃÁÈ¿¥¤Ø¤Î¼è¤ê¹þ¤ß¤Î¸º¾¯¤Ë¤è¤ë¤â¤Î¤«¤â¤·¤ì¤Ê¤¤¡¥ÊìÂλÀÁÇÅêÍ¿¤Ë¤è¤ëÂÛ»ù·ìÃæÆý»À¡¤¥°¥ë¥³¡¼¥¹¡¤ ¥È¥ê¥°¥ê¥»¥ê¥É¤Ø¤Î±Æ¶Á¤Ï¤¤¤Þ¤À¤è¤¯¤ï¤«¤Ã¤Æ¤¤¤Ê¤¤¡¥ÂÛ»ù·ìpH¤Ï¥°¥ë¥³¡¼¥¹ÅêÍ¿¤Ë¤è¤ê¸º¾¯¤¹¤ë¤³¤È¤¬´Ñ»¡¤µ¤ì¤Æ¤¤¤ë¡¥ÂÛ»ù¤Ø¤Î¹â¥«¥í¥ê¡¼±ÉÍÜÅêÍ¿ÎÅË¡¤Î²ÄǽÀ­¤ò¼¨½Ô¤·¤Æ¤¤¤ë¡¥

¡¡

 4. PUBS¤È½¾Í褫¤é¤ÎÈ󿯽±ÅªÂÛ»ùɾ²ÁË¡¤ÎÈæ³Ó

a. ¥Î¥ó¥¹¥È¥ì¥¹¥Æ¥¹¥È(NST)

¥Î¥ó¥¹¥È¥ì¥¹¥Æ¥¹¥È(nonstress test; NST)¤Ï¡¤ºÇ¤â°ìÈÌŪ¤Ë»È¤ï¤ì¤Æ¤¤¤ëÈ󿯽±ÅªÂÛ»ùɾ²ÁË¡¤Ç¤¢¤ë¡¥ IUGR 38Îã¤ËÂФ·¤ÆPUBS¤ò¹Ô¤Ã¤¿Êó¹ð(21)¤Ç¤Ï¡¤ÂÛ»ù¤ÎÄã»ÀÁÇ·ì¾É¡¤¥¢¥·¥É¡¼¥·¥¹¤ÈÂÛ»ù¿´Çï¿ô°Û¾ï¥Ñ¥¿¡¼¥ó¤Ë¤ÏÌ©Àܤʴط¸¤¬Ç§¤á¤é¤ì¤¿¡¥¤¤¤ï¤æ¤ë¥ê¥¢¥¯¥Æ¥£¥Ö(reactive)¥Ñ¥¿¡¼¥ó¤ò¤È¤ëÂÛ»ù¤Ç¤Ï¡¤È¯°éÃٱ䤬¤¢¤Ã¤Æ¤â¡¤¤½¤Î¤Û¤È¤ó¤É¤ÏPO2¤¬Àµ¾ïÈÏ°ÏÆâ¤Ë¤¢¤Ã¤¿¡¥NST¤Ç¤Ï¸í¤Ã¤Æ¥¸¥¹¥È¥ì¥¹¤È¤µ¤ì¤¿Ç¥¿±Ãæ´ü¤ÎÂÛ»ù¤ËPUBS¤ò»Ü¹Ô¤¹¤ë¤³¤È¤Ë¤è¤ê¡¤ÉÔɬÍפʰå³ØŪ²ðÆþ¤òËɤ°¤³¤È¤¬¤Ç¤­¤¿¤È¤¹¤ëÊó¹ð¤â¤Ê¤µ¤ì¤Æ¤¤¤ë(22)(23)¡¥Donner¤é(24)¤Ï¡¤IUGR»ù¤Î¥¢¥·¥É¡¼¥·¥¹Æ±Äê¤Ë´Ø¤·¤Æ¡¤NST¤Î´¶ÅÙ(sensitivi£ôy) 45%¡¤ÍÛÀ­Í½ÃÎΨ¡Êpositive predictive value¡Ë 95%¤ÈÊó¹ð¤·¤Æ¤¤¤ë¤¬¡¤ÌäÂê¤Ï¤½¤Î¥¢¥·¥É¡¼¥·¥¹¤ÎÄêµÁ¤Ç¤¢¤ê¡¤¼ÂºÝ¤ËÈà¤é¤ÎÊó¹ð¤Ç¤ÏpH¤¬7.20°Ê²¼¤ÎÂÛ»ù¤Ï1Î㤷¤«Â¸ºß¤·¤Ê¤«¤Ã¤¿¡¥

b. Biophysical profile (BPP)

Manning¤é¤ÎÊó¹ð(25)¤Ë¤è¤ë¤È¡¤biophysical profile score (BPS) ¤ÈÆ­ÂÓÀÅÌ®·ìpH¤È¤Î´Ö¤ËÌ©Àܤʴط¸¤òǧ¤á¤¿¡¥BPS 8ÅÀ°Ê¾å¤ÎÀµ¾ï¤Ç¤ÏÂÛ»ù¥¢¥·¥É¡¼¥·¥¹(pH 7.25°Ê²¼¡Ë¤ò´°Á´¤Ë½ü³°¤Ç¤­¤¿¡¥BPS 4ÅÀ°Ê²¼¤Î¾ì¹ç¤Î¥¢¥·¥É¡¼¥·¥¹¤Î´¶ÅÙ¤Ï100%¡¤ÍÛÀ­Í½ÃÎΨ¤Ï41%¤Ç¤¢¤Ã¤¿¡¥24Îã¤ÎIUGR»ù¤ËÂФ¹¤ëƱÍͤ覵æ(26)¤Ç¤Ï¡¤BPS¤ÈÂÛ»ù¤Î¥¢¥·¥É¡¼¥·¥¹¤È¤ÎÌ©ÀܤʴØÏ¢¤¬¼¨¤µ¤ì¤Æ¤¤¤ë¡¥BPS¤¬5ÅÀ°Ê²¼¤Ç¤Ï50¡ó¤Ë»À·ì¾É(acidemia)¤¬Â¸ºß¤·¤¿¡¥

c. Ķ²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬

Weiner (27)¤Ï¡¤Ç¥¿±25½µ°Ê¹ß¤Ç¾¡ÂÓÆ°Ì®·ìή®ÅÙÇÈ·Á¤ÎS/DÈæ(systolic/diastolic ratio)¤¬3.5°Ê¾å¤ò¼¨¤¹¾ì¹ç¡¤S/DÈæ¤ÈçÁÂÓÀÅÌ®·ìPO2¤¬¶¯¤¤Áê´Ø¤ò¤â¤Ä¤³¤È¤òÊó¹ð¤·¤¿¡¥¤Þ¤¿¡¤çÁÂÓÆ°Ì®·ìή¤Ç³ÈÄ¥´üÅÓÀä¤ò¼¨¤¹¾ÉÎã¤Ï¡¤¹âΨ¤ÇÄã»ÀÁÇ·ì¾É¤È¥¢¥·¥É¡¼¥·¥¹¤òÄ褷¤Æ¤¤¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤ë(24)(28)¡¥çÁÂÓÆ°Ì®·ìή®ÅÙÇÈ·Á¤ÎS/DÈæ¤äPI (pulsatililty index)ÃͤÎÁýÂç¤ÏÂÛÈפǤΥ¬¥¹¸ò´¹¤ÎÄã²¼¤ò¼¨¤·¡¤³ÈÄ¥´ü·ìή¤ÎÅÓÀä¤ÏÄã»ÀÁǾɡ¤¥¢¥·¥É¡¼¥·¥¹¤Î¸²ºß²½¤ò°ÕÌ£¤¹¤ë¤È¤¤¤¨¤ë¡¥

¡¡

 5. PUBS¤Ë¤è¤ëÂÛ»ùɾ²Á¤ÎŬ±þ¤È¸Â³¦

a. Ŭ±þ

½ÐÀ¸Âΰ¡¤Î10¥Ñ¡¼¥»¥ó¥¿¥¤¥ë°Ê²¼¤òlight-for-dates»ù¤È¤¹¤ëÂè10ÈǹñºÝ¼ÀÉÂʬÎà(ICD 10)¤ÎÄêµÁ¤Ë½¾¤¦¤È¡¤ÂÛ»ù10¿Í¤Ë1¿Í¤Ïȯ°éÃÙ±ä¤È¤¤¤¦¤³¤È¤Ë¤Ê¤ë¡¥¤½¤Î¤Ê¤«¤ÎÌóȾʬ¤ÏÂÛÈ×µ¡Ç½ÉÔÁ´¤äÊìÂÎÂÛ»ù¼À´µ¤Ê¤É¼ÂºÝ¤Ë²¿¤é¤«¤Î¸¶°ø¤Ë¤è¤êȯ°é¤¬Á˳²¤µ¤ì¤Æ¤¤¤ë¤Î¤ËÂФ·¡¤»Ä¤ê¤ÎȾʬ¤Ï²È²Ū¡¦ÂμÁŪÁÇ°ø¤«¤éÊ¿¶Ñ¤è¤ê¾®ÊÁ¤À¤¬¤½¤Î»ù¤È¤·¤Æ¤ÏÀµ¾ïÈÏ°ÏÆâ¤ÎÂÛÆâȯ°é¤È¤¤¤¨¤ë¤â¤Î¤Ç¤¢¤ë¡¥ ¤â¤·IUGR¤Î¿ÇÃǤ¬Àµ³Î¤Ë¹Ô¤ï¤ì¤ë¤Î¤Ê¤é¡¤È¯°éÃÙ±äÂÛ»ù¤Ï¤¹¤Ù¤ÆPUBS¤ÎŬ±þ¤È¤Ê¤ë¤«¤È¤¤¤¨¤Ð¡¤Åú¤¨¤ÏÈݤǤ¢¤ë¡¥´ñ·Á¤òȼ¤ï¤º¡¤Ç¥¿±¸å´ü¤«¤éȯ¾É¤¹¤ëȯ°éÃÙ±ä¤Ë¤ª¤¤¤Æ¤Ï, PUBS¤Ë¤è¤Ã¤Æ½ÅÍפÊÎ×¾²Åª¾ðÊó¤¬ÆÀ¤é¤ì¤ë¤È¤Ï¹Í¤¨¤é¤ì¤Ê¤¤¡¥¤³¤ì¤é¤Î¿¤¯¤Ïasymmclrical IUGR¤Ç¤¢¤ê¡¤¤¤¤ï¤æ¤ëÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤Ã¤ÆÀ¸¤¸¤ë¤â¤Î¤Ç¤¢¤ë¡¥²¾¤Ë1¡Á2½µ´ÖÁ᤯ǥ¿±35¡Á36½µ¤Ç½ÐÀ¸¤·¤¿¤È¤·¤Æ¤â¡¤»ù¤Ë¤È¤Ã¤Æ¤ÏPUBS¤ò¼õ¤±¤ë¤è¤ê¥ê¥¹¥¯¤Ï¾®¤µ¤¤¤È¹Í¤¨¤é¤ì¤ë¡¥

¤¹¤Ê¤ï¤ÁPUBS¤ÎŬ±þ¤Ï¡¤È¯°éÃٱ䤬¤­¤ï¤á¤Æ½Å¾É¤Ç¤¢¤Ã¤¿¤êÇ¥¿±32½µ°ÊÁ°¤ÎÁá´ü¤«¤éǧ¤á¤é¤ì¤¿¤ê¤¹¤ë¤«¡¤¤¢¤ë¤¤¤Ïsymmetrical IUGR¤Î¾ì¹ç¤Ê¤É¤È¹Í¤¨¤é¤ì¤ë¡¥Àµ¾ïȯ°é¤ÎÂÛ»ù¤«¤éPUBS¤Î¥ê¥¹¥¯¤ò²óÈò¤¹¤ë¤¿¤á¤Ë¤Ï¡¤ÂÛ»ù¿äÄêÂνŤÀ¤±¤Ç¤Ï¤Ê¤¯¡¤ÂÛ»ùÊ¢°Ï¤ò¸·Ì©¤Ëɾ²Á¤·¤ÆÊ¿¶Ñ¤Î5¥Ñ¡¼¥»¥ó¥¿¥¤¥ë°Ê²¼¤Î¤ß¤òPUBS¤ÎŬ±þ¤È¤¹¤ë¤³¤È¤âɬÍפǤ¢¤ë¡¥IUGR¤Î¸¶°ø¤È¤·¤Æ¤Ï¡¤À÷¿§Âΰ۾ï¡ÊÌó20¡ó)¡¤ÀèÅ·´¶À÷¡ÊÌó10¡ó)¡¤ÂÛ»ù¤Î·ÏÅýŪ¼À´µ¡ÊÌó1¡ó¡Ë¤Ê¤É¤¬¤¢¤ê¡¤ÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤êÀ¸¤¸¤ë¤â¤Î¤ÏÁ´ÂΤÎ70¡óÄøÅ٤Ǥ¢¤ë¡¥

ÂÛÈ×µ¡Ç½ÉÔÁ´¤Ë¤è¤Ã¤ÆÂÛ»ù¤¬ËýÀ­Äã»ÀÁǤ˴٤äƤ¤¤ë¤È¤­¤Ï¡¤ÊìÂΤ˹âÇ»ÅÙ»ÀÁǵÛÆþÎÅË¡¤ò¹Ô¤¦¤³¤È¤¬¤¢¤ë(29)¡¥»ÀÁÇÅêÍ¿¤Ë¤è¤êÂÛ»ù¤Î»ÀÁDz½¡Êoxygenation¡Ë¤¬²þÁ±¤·¡¤ÂÛÈ×·ì´ÉÄñ¹³¤Î¸º¾¯¤ÈÂÛ»ùÃæÂçǾ½õÌ®¤Î·ì´ÉÄñ¹³¤Î¾å¾º¤¬µ¯¤³¤ë¤³¤È¤ÏÃΤé¤ì¤Æ¤¤¤ë¡¥¹âÇ»ÅÙ»ÀÁÇÅêÍ¿¤¬ÂÛÈ×µ¡Ç½ÉÔÁ´¤ò¹çÊ»¤·¤¿Ç¥ÉؤÎÇ¥¿±´ü´Ö¤ò±äŤµ¤»¤ë¸ú²Ì¤¬¤¢¤ë¤«¤Ë¤Ä¤¤¤Æ¤Ï¤Þ¤À¾ÚÌÀ¤µ¤ì¤Æ¤¤¤Ê¤¤¤¬¡¤»ÒµÜ³°¤Ç¤ÎÀ¸Â¸¤¬¤¤¤Þ¤À¸·¤·¤¤»þ´ü¤Î̤½Ï¤ÊÂÛ»ù¤Ë¤Ï»î¤ß¤ë²Á²Á¤Ï¤¢¤ë¤À¤í¤¦¡¥¤¿¤À¤·¡¤»ÀÁÇÅêÍ¿¤òÃæ»ß¤·¤¿Ä¾¸å¤ËÂÛ»ù¤Î¾õÂÖ¤¬µÕ¤Ë°­²½¤¹¤ë¤³¤È¤¬¤¢¤ë¤Î¤Ç¡¤Ãí°Õ¤¬É¬ÍפǤ¢¤ë¡¥

PUBS¤Ë¤è¤ëÂÛ»ù·ì±Õ¥¬¥¹¤Î¬Äê¤Î¤â¤¦¤Ò¤È¤Ä¤ÎŬ±þ¤È¤Ê¤ë¤«¤â¤·¤ì¤Ê¤¤¤Î¤Ï¡¤FHR¥â¥Ë¥¿¥ê¥ó¥°¤Ë¤ª¤¤¤ÆÈó¾ï¤Ë²ò¼á¤ÎÆñ¤·¤¤¥Ñ¥¿¡¼¥ó¤¬À¸¤¸¤¿¤È¤­¤Ç¤¢¤ë¡¥¤¿¤È¤¨¤ÐShah¤é (22)¤Ï¡¤Ç¥¿±24½µ¤Ç´ðÀþºÙÊÑÆ°¤Î¾Ã¼º¤ÈÃÙȯ°ì²áÀ­½ùÌ®¤¬À¸¤¸¤¿Îã¤ä¡¤Ç¥¿±27½µ¤ÇÊÑÆ°°ì²áÀ­½ùÌ®¤ÈÃÙȯ°ì²áÀ­½ùÌ®¤¬ÉÑȯ¤¹¤ëÎã¤ò¼è¤ê¾å¤²¤ÆÊó¹ð¤·¤¿¡¥ ¤â¤·PUBS¤Ë¤è¤Ã¤ÆÂÛ»ù¤Î¥¢¥·¥É¡¼¥·¥¹¤¬±°Ç§¤µ¤ì¤ì¤ÐµÞ®¿ëÊÚ¤ÎŬ±þ¤È¤Ê¤ë¡¥¤¿¤À¤·¡¤PUBS¤È¤¤¤¦¤Î¤Ï·Ñ³¤¹¤ë»ö¾Ý¤Ë¤ª¤±¤ë¤¿¤À°ìÅÀ¤Ç¤Î¾õÂÖɾ²Á¤Ç¤¢¤ë¤¿¤á¡¤°ìÈÌŪ¤Ë¤¤¤Ã¤ÆPUBS¤¬Å¬±þ¤È¤Ê¤ë¤«¤ÏÆñ¤·¤¤¡¥¥¢¥·¥É¡¼¥·¥¹¤¬¿Ê¹Ô¤¹¤ë¾ì¹ç¤Ç¤Ï¥â¥Ë¥¿¡¼¤Ëɬ¤ºÊѲ½¤¬µ¯¤³¤Ã¤Æ¤¯¤ë¤Ï¤º¤Ç¤¢¤ë¡¥ ¤Þ¤¿²¾¤ËpH¤¬Àµ¾ï¤Ç¤¢¤ë¤³¤È¤¬¤ï¤«¤Ã¤Æ¤â¡¤¤½¤Î»ö¼Â¤Ï»ÒµÜ¼ý½Ì»þ¤Ë¤ª¤±¤ëÂÛ»ùÄã»ÀÁǾɤòÈÝÄꤹ¤ë¤â¤Î¤Ç¤Ï¤Ê¤¯¡¤»ÒµÜ¼ý½Ì¤¬Â³¤¯¤È¤È¤â¤Ë¥¢¥·¥É¡¼¥·¥¹¤Ë¿Ê¤ó¤Ç¤¤¤¯¤«¤â¤·¤ì¤Ê¤¤¡¥

¤³¤Î¾ì¹ç¡¤PUBS¤ÎÂå¤ï¤ê¤Ë2¤Ä¤ÎÊýË¡¤¬¹Í¤¨¤é¤ì¤ë¡¥¤Ò¤È¤Ä¤ÏÊìÂΤ˥ޥ¹¥¯¤Ç»ÀÁÇÅêÍ¿¤ò¹Ô¤¦¤³¤È¤Ç¤¢¤ë¡¥»ÀÁÇÅêÍ¿¤Ë¤è¤êÃÙȯ°ì²áÀ­½ùÌ®¤¬¾Ã¼º¤·¤¿¤¬¡¤»ÀÁÇÅêÍ¿¤òÃæÃǤ¹¤ë¤ÈºÆÅٽи½¤¹¤ë¾ì¹ç¤Ï¡¤ÌÀ¤é¤«¤Ë¤³¤Î½ùÌ®¤ÏÂÛ»ùÄã»ÀÁǾɤò°ÕÌ£¤·¤Æ¤¤¤ë¡¥ ¤â¤¦¤Ò¤È¤Ä¤ÎÊýË¡¤Ï¡¤FHR¥â¥Ë¥¿¥ê¥ó¥°¤Î½ê¸«¤¬ÌÀ¤é¤«¤Ë¤Ê¤ë¤Þ¤Ç¤½¤Î¤Þ¤Þ¥â¥Ë¥¿¥ê¥ó¥°¤ò·Ñ³¤¹¤ë¤³¤È¤Ç¤¢¤ë¡¥

b. ÌäÂêÅÀ

PUBS¤Ë¤è¤ëçÁÂӷ쥬¥¹¤Î¬Äê¤ÎĹ½ê¤Ï¡¤²¿¤è¤ê¤âºÇ¤âÀµ³Î¤ÊÂÛ»ùɾ²Á¤À¤È¤¤¤¦¤³¤È¤Ç¤¢¤ë¤¬¡¤°ìÈÌŪ¤Ê¸¡ººË¡¤È¤·¤ÆÉáµÚ¤·¤Æ¤¤¤ë¤È¤Ï¤¤¤¨¤Ê¤¤¡¥¼êµ»Åª¤Ë¤¢¤ëÄøÅ٤ν¤Îý¤òÍפ¹¤ë¤È¤«¡¤ºÎ·ì¤Ë»þ´Ö¤È¼ê´Ö¤¬¤«¤«¤ë¤Ê¤É¤ÎÍýͳ¤â¤¢¤ë¤¬¡¤ºÇÂç¤ÎÍýͳ¤È¤·¤Æ°å³ØˡΧŪ¡Êmedicolegal¡Ë¤ÊÇÛθ¤¬Â¸ºß¤¹¤ë¤È¹Í¤¨¤é¤ì¤ë¡¥PUBS¤¬¸¶°ø¤È¤µ¤ì¤ëÂÛ»ù»àË´¤ÏÌó1¡ó¤Ç¤¢¤ë¡¥ PUBS¤ÎºÇ¤â°ìÈÌŪ¤ÊŬ±þ¤ÏÂÛ»ùÀ÷¿§Âΰ۾ï¤Î¿×®¿ÇÃǤÈÂÛ»ùÍÏ·ìÀ­¼À´µ»þ¤ÎÂÛ»ù¾õÂÖɾ²Á¤Ç¤¢¤ë¤¬¡¤ ¤³¤Î¾ì¹çÂÛ»ù¤¬ÉÔ¼£¤Î°Û¾ï¤Ç¤¢¤Ã¤¿¤ê¡¤¼À´µ¤Î¥ê¥¹¥¯¤¬¤­¤ï¤á¤Æ¹â¤¤²ÄǽÀ­¤¬¤¢¤ê¡¤Àµ³Î¤Ê¾ðÊó¤òÍ¿¤¨¤Æ¤¯¤ì¤ëPUBS¤¬Å¬±þ¤È¤Ê¤ëÍýͳ¤Ï½½Ê¬¤Ë¤¢¤ë¡¥ ¤·¤«¤·¡¤ÂÛ»ù·ì±Õ¥¬¥¹¤ª¤è¤Ó»À±ö´ðÊ¿¹Õɾ²Á¤Î¤¿¤á¤ÎPUBS¤Ë¤ª¤¤¤Æ¤Ï¡¤FHR¥â¥Ë¥¿¥ê¥ó¥°¤äĶ²»ÇȥɥץéË¡¤Ê¤É¤ÎÂåÂØŪɾ²ÁË¡¤¬Â¸ºß¤·¤Æ¤¤¤ë°Ê¾å¡¤¤½¤Î»Ü¹Ô¤Ë¤¢¤¿¤Ã¤Æ¤Ï½½Ê¬¤Ê¹Íθ¤¬É¬ÍפȤʤ롥

½ÐÀ¸»þ¤ÎçÁÂÓÆ°Ì®·ìpH¤ÈPO2¤¬¿·À¸»ù¤Î¾õÂÖ¤òɾ²Á¤¹¤ëºÇ¤âÍ¥¤ì¤¿»Øɸ¤Ç¤¢¤ë¤³¤È¤Ï¤¹¤Ç¤Ë¹­¤¯¼õ¤±Æþ¤ì¤é¤ì¤Æ¤¤¤ë¤¬¡¤ ¤â¤·½ÐÀ¸Á°¤ÎPUBS¤Ë¤è¤êÂÛ»ù¤ÎÄã»ÀÁÇ·ì¾É¤ä¥¢¥·¥É¡¼¥·¥¹¤¬Æ±Äꤵ¤ì¡¤Áá´ü¤Î¿ëÊÚ¤¬¤Ê¤µ¤ì¤ë¤³¤È¤Ë¤Ê¤ì¤Ð¡¤»ù¤Îͽ¸å¤Ï²þÁ±²Äǽ¤Ç¤¢¤í¤¦¤«¡¥ ¤½¤Î¤¿¤á¤Ë¤Ï¡¤PUBS¤Ë¤è¤ë°ìÅÀ¤Îɾ²Á¤¬»ù¤ÎÀµ¤·¤¤¾õÂÖ¤òÈ¿±Ç¤·¤Æ¤¤¤ë¤«¡¤È󿯽±Åª¤ÊFHR¥â¥Ë¥¿¥ê¥ó¥°¤äçÁÂÓÆ°Ì®¥É¥×¥é·ìή®ÅÙÇÈ·Áɾ²Á¤Ç¤Ï¤ï¤«¤é¤Ê¤¤Äã»ÀÁǾɡ¤¥¢¥·¥É¡¼¥·¥¹¤¬Â¸ºß¤¹¤ë¤«¡¤PUBS¤Ë¤è¤ëÉûºîÍѤòĶ¤¨¤ë¥á¥ê¥Ã¥È¤¬Â¸ºß¤¹¤ë¤«¡¤¤Ê¤É¤ÎÌäÂêÅÀ¤ò¸¡Æ¤¤¹¤ëɬÍפ¬¤¢¤ë¡¥

PUBS¤Ë¤è¤êÆÀ¤é¤ì¤¿ÃͤϤ­¤ï¤á¤ÆÀµ³Î¤Ç¤Ï¤¢¤ë¤¬¡¤ ¤½¤Î·ë²Ì¤¬¼¨¤¹¤Î¤ÏÂÛ»ù¾õÂ֤Τ¢¤ë°ìÅÀ¤Ç¤¢¤ê¡¤·Ñ³Ū¤ÊÊѲ½¤òɽ¸½¤·¤Æ¤¤¤ë¤ï¤±¤Ç¤Ï¤Ê¤¤¡¥Àü»ÉÁàºî¤½¤Î¤â¤Î¤Ë¤è¤ë»ÒµÜ¼ý½Ì¤¬ÂÛ»ù·ì±Õ¥¬¥¹Ãͤ˱ƶÁ¤òÍ¿¤¨¤ë²ÄǽÀ­¤â¤¢¤ë¡¥²¿²ó¤«Â³¤±¤ÆPUBS¤ò¹Ô¤¦¤³¤È¤¬¤Ç¤­¤ì¤ÐÀµ³Î¤Ê¾õÂÖɾ²Á¤Èͽ¸åͽ¬¤¬²Äǽ¤Ë¤Ê¤ë¤Î¤«¤â¤·¤ì¤Ê¤¤¤¬¡¤¿¯½±Åª¸¡ºº¤Ç¤¢¤ë¤¿¤á¤ËÆñ¤·¤¤¡¥

NST¡¤Ä¶²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬¡¤BPP¤È¤¤¤Ã¤¿È󿯽±Åª¸¡ººË¡¤È¤ÎÈæ³Ó¤Ç¤Ï¤É¤¦¤À¤í¤¦¤«¡¥PUBS¤¬°ìÈ̤ËÉáµÚ¤·¡¤ÂÛ»ù¤«¤éľÀÜ·ì±Õ¥¬¥¹¤äpH¤Ê¤É¤Î¿®Íê¤Ç¤­¤ë¾ðÊó¤òÆÀ¤ë¤³¤È¤¬¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤Ã¤Æ¡¤¤¢¤ë°ÕÌ£¤Ç¤ÏÈéÆù¤Ê¤³¤È¤Ë½¾Íè¤ÎÈ󿯽±Åª¤ÊÂÛ»ùɾ²ÁË¡¤ÎÍ­¸úÀ­¤¬³Î¤«¤á¤é¤ì¤ë¤³¤È¤Ë¤â¤Ê¤Ã¤¿¡¥¤¿¤È¤¨¤ÐPUBS¤Î¥Ç¡¼¥¿¤Ë¤è¤ê¡¤´û¸¤ÎNST¤äĶ²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬¡¤BPP¤Ê¤É¤Ë¤è¤ëÂÛ»ùÄã»ÀÁǾɤ䥢¥·¥É¡¼¥·¥¹¤Î¿ÇÃǤä½Å¾ÉÅÙȽÄê¤ÎÀµ³Î¤µ¤¬¸¡¾Ú¤µ¤ì¤¿¤È¤¤¤¦Ì̤¬¤¢¤ë¡¥¤½¤Î·ë²Ì¡¤¿¯½±Åª¤ÊPUBS¤Ë¤è¤ë·ì±Õ¥¬¥¹¤äpH¤ÎľÀܬÄê¤Î°ÕµÁ¤¬Íɤ餤¤Ç¤­¤¿¤Î¤â»ö¼Â¤Ç¤¢¤ë(30)(31)¡¥

Nicolini¤é(32)¤ÎçÁÂÓÆ°Ì®·ìή³ÈÄ¥´üÅÓÀä¾ÉÎã¤ËÂФ¹¤ëPUBS»Ü¹ÔÎã¤Î¸¡Æ¤¤Ë¤è¤ë¤È¡¤ÅÓÀä¤Î¤Ê¤¤¾ÉÎã¤ËÈæ¤Ù¤ÆÍ­°Õ¤ËÄã»ÀÁÇ·ì¾É¡¤¥¢¥·¥É¡¼¥·¥¹¤òÄ褷¤Æ¤¤¤¿¤¬¡¤³ÈÄ¥´üÅÓÀäÎã¤Î¤Ê¤«¤Ç¤Îͽ¸åÎɹ¥·²¤Èͽ¸åÉÔÎÉ·²¤È¤Î´Ö¤Ë¤Ï·ì±Õ¥¬¥¹¡¤»À±ö´ðÊ¿¹Õ¤ÎÃͤ˺¹¤Ï¤Ê¤«¤Ã¤¿¡¥¤¹¤Ê¤ï¤ÁPUBS¤Ë¤è¤ëÂÛ»ù·ìɾ²Á¤Ï¡¤Í½¸åȽÄê¤È¿ëÊÚ·èÄê¤Ë´Ø¤·¤ÆÎ×¾²Åª°ÕµÁ¤ÏÄ㤤¤È·ëÏÀ¤·¤Æ¤¤¤ë¡¥

¤·¤«¤·Ê̤ʻëÅÀ¤«¤éPUBS¤Ë¤è¤ëÂÛ»ùɾ²Á¤Î°ÕµÁ¤òǧ¤á¤Æ¤¤¤ëDonner¤é¤Î¸¦µæ(24)¤â¤¢¤ë¡¥¤½¤ì¤Ë¤è¤ë¤È¡¤½¾Íè¤ÎÈ󿯽±ÅªÂÛ»ùɾ²ÁË¡¤Ç°Û¾ï½ê¸«¤ò¼¨¤µ¤Ê¤¤¤Ë¤â¤«¤«¤ï¤é¤º¡¤PUBS¤Ë¤è¤Ã¤ÆÄã»ÀÁÇ·ì¾É¤ä¥¢¥·¥É¡¼¥·¥¹¤òǧ¤á¤¿IUGR»ù¤¬16%¤Ë¸ºß¤·¤¿¤È¤¤¤¦¡¥Èà¤é¤Î·ëÏÀ¤Ç¤Ï¡¤1²ó¤ÎPUBS¤ÇpH¤ÈPO2¤ò¬Äꤹ¤ë¤³¤È¤Ë¤è¤ê,NST¤äĶ²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬¤Ê¤É¤Ç°Û¾ï½ê¸«¤òÄ褷¤¿Îã¤òͽ¸åÎɹ¥¤Èͽ¸åÉÔÎɤÎ2·²¤ËʬÎह¤ë¤³¤È¤¬¤Ç¤­¤¿¡¥¤¹¤Ê¤ï¤Á¡¤IUGR»ù¤Ç¤âÈ󿯽±ÅªÉ¾²ÁË¡¤ÈPUBS¤ÎξÊý¤ÇÀµ¾ï¤Ç¤¢¤ë¤Ê¤é¤Ð¡¤¤½¤ì¤Ï²¿¤ÎÉÂŪ¤Ê°ÕµÁ¤ò¤â¤¿¤Ê¤¤Àµ¾ïÂÛ»ù¤È°·¤Ã¤Æ¤è¤¤¤È¤¤¤¦¤â¤Î¤Ç¤¢¤ë¡¥

IUGR»ù¤òÁá´ü¤ËÊڽФ¹¤ë¤«¤É¤¦¤«¤Ï¡¤°ìÈÌŪ¤Ë¤Ï°ÍÁ³¤È¤·¤ÆÇ¥¿±½µ¿ô¡¤¿äÄêÂνš¤È󿯽±ÅªÉ¾²ÁË¡¤Ê¤É¤ò´ª°Æ¤·¤Æ¹Ô¤ï¤ì¤Æ¤¤¤ë¡¥»ÄÇ°¤Ê¤¬¤é¸½ºß¤Î¤È¤³¤í¡¤PUBS¤Ë¤è¤Ã¤ÆÂÛ»ù¤ÎľÀÜɾ²Á¤ò¹Ô¤¦¤³¤È¤Ë¤è¤ê¼þ»º´üͽ¸å¤ò²þÁ±¤Ç¤­¤¿¤È¤¤¤¦Êó¹ð¤Ï¤Ê¤¤¡¥¤·¤«¤·PUBS¤ËÍѤ¤¤¿ÂÛ»ùɾ²Á¤ÎÍ­ÍÑÀ­¤ò¸¡Æ¤¤¹¤ë¤¿¤á¤Ë¤Ï¡¤¤½¤Î¥¨¥ó¥É¥Ý¥¤¥ó¥È¤Ë²¿¤ò¤ª¤¯¤«¤¬½ÅÍפȤʤ롥¼þ»º´ü¤ÎÀ¸Ì¿Í½¸å¤Ë¤È¤É¤Þ¤é¤º½ÐÀ¸¸å¤Î¿À·Ð³ØŪͽ¸å¤Þ¤Ç»ëÌî¤ò¹­¤²¤¿¾ì¹ç¡¤ÂÛÆâ¤ÇĹ´ü´ÖÄã»ÀÁǴĶ­¤ËÇøϪ¤µ¤ì¤Æ¤¤¤ë¤è¤ê¤â»ÒµÜ³°¤Ç½¸Ãæ¼£ÎŤò¼õ¤±¤¿¤Û¤¦¤¬¤è¤¤¾ì¹ç¤â½½Ê¬¤Ë¹Í¤¨¤é¤ì¤ë¤Ç¤¢¤í¤¦¡¥

¾åµ­¤Ë½Ò¤Ù¤Æ¤­¤¿¤è¤¦¤ÊPUBS¤Î¸Â³¦¤È¤½¤ÎÉûºîÍѤ¬ÃΤé¤ì¤ë¤è¤¦¤Ë¤Ê¤ë¤È¡¤IUGR»ù¤ËÂФ¹¤ë¥ë¡¼¥Á¥ó¤ÊPUBS»Ü¹Ô¤Ë¤Ä¤¤¤Æ¤Ïµ¿Ìä»ë¤â¤µ¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤Æ¤­¤¿¡¥IUGR¤Ë¤ª¤¤¤Æ¤Ï°ìÈ̤ËÀ÷¿§Âΰ۾ï¤ÎÉÑÅÙ¤Ï10¡ó°Ê²¼¤Ç¤¢¤ë¡¥½¾Í褫¤é¤ÎÈ󿯽±Åª¸¡ºº¤Ï¤«¤Ê¤êÀµ³Î¤ËÂÛ»ù¥¢¥·¥É¡¼¥·¥¹¤Î̵ͭ¤òȽÄê¤Ç¤­¤ë¤Î¤Ç¡¤PUBS¤Ë¤è¤ë»À±ö´ðÊ¿¹Õ¤ÎľÀÜɾ²Á¤Î¥á¥ê¥Ã¥È¤Ï¤½¤Î¥ê¥¹¥¯¤ò¾å²ó¤é¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡¥º£Æü¤Ç¤Ï¡¤IUGR»ù¤ËÂФ¹¤ëPUBS¤Î»Ü¹Ô¤Ï¡¤À÷¿§Âΰ۾ï»ù¤ËÂФ¹¤ëÉÔɬÍפÊÄ벦ÀÚ³«¤òÈò¤±¤ë¤¿¤á¤Ë¼ç¤È¤·¤Æ¹Ô¤ï¤ì¤ë¤È¤¤¤Ã¤Æ¤â¤è¤¤¡¥

¡¡

 ¤ª¤ï¤ê¤Ë

PUBS¤Ë¤è¤Ã¤Æ¡¤¤¤¤Þ¤À̤½Ï¤ÊÂÛ»ù¤Ë´Ø¤·¤Æ¤â»ÒµÜÆâ¤Ç·ì±Õ¥¬¥¹¤ò¬Äꤹ¤ë¤³¤È¤¬¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ê¡¤Â¿¤¯¤Î¶½Ì£¿¼¤¤À¸Íý³ØŪÃ諤¬ÃΤé¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡¥ ¤·¤«¤·»ÄÇ°¤Ê¤¬¤é¡¤IUGR»ù¤Î´ÉÍý¤Ë¤ª¤±¤ëPUBS¤ÎÍ­ÍÑÀ­¤Ë¤Ä¤¤¤Æ¤Ï¤¤¤Þ¤Àµ¿ÌäÉ䤬ÉÕ¤±¤é¤ì¤Æ¤¤¤ë¡¥¤½¤ì¤Ï¡¤PUBS¤¬¤¢¤ë°ìÅÀ¤Ç¤ÎÂÛ»ùɾ²Á¤Ë¤¹¤®¤Ê¤¤¤³¤È¤È¿¯½±ÅªÁàºî¤Ëȼ¤¦´í¸±À­¤Î2¤Ä¤ÎÍýͳ¤«¤é¡¤½¾Í褫¤é¤ÎÈ󿯽±ÅªÂÛ»ùɾ²Á¤òĶ¤¨¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¤È°ÌÃ֤Ť±¤é¤ì¤Æ¤¤¤ë¤«¤é¤Ç¤¢¤ë¡¥

¤â¤·¡¤½¾Í褫¤é¤ÎÈ󿯽±Åª¤ÊÂÛ»ù¥â¥Ë¥¿¥ê¥ó¥°¤Ç¤ÏÀµ¾ï¤Ë¤â¤«¤«¤ï¤é¤º¡¤ÂÛ»ù¤Ë·ÚÅÙ¤ÎÄã»ÀÁÇ·ì¾É¤ä¥¢¥·¥É¡¼¥·¥¹¤¬Â¸ºß¤·¤Æ¤¤¤¿¤È¤¹¤ì¤Ð¡¤¤½¤ì¤ÏÂÛ»ù¤Ë¤È¤Ã¤Æ¿¼¹ï¤ÊÌäÂê¤ò°ÕÌ£¤¹¤ë¤Î¤À¤í¤¦¤«¡¥ NST¤äBPP¤Ê¤É¤Ï·ë¶É¤Î¤È¤³¤íÂÛ»ù¤ÎÃæ¿õ¿À·Ð·Ïµ¡Ç½¤òÈ¿±Ç¤·¤Æ¤¤¤ë¤È¹Í¤¨¤é¤ì¤ë¤Î¤Ç¡¤çÁÂӤǤηì±Õ¥¬¥¹Ãͤè¤ê¤Ï¡¤ ¤â¤·¤«¤¹¤ë¤È½ÅÍפʽ긫¤«¤â¤·¤ì¤Ê¤¤¡¥ ¤·¤«¤·¡¤ ¤â¤·NST¤äBPP¤¬Àµ¾ï¤Ê¤È¤­¤Ç¤â¡¤Äã»ÀÁÇ·ì¾É¤¬ÂÛ»ùÃæ¿õ¿À·Ð·Ï¤Ë²¿¤é¤«¤Î¥À¥á¡¼¥¸¤òµÚ¤Ü¤¹¤Î¤Ç¤¢¤ì¤Ð¡¤PUBS¤Ë¤è¤ë·ì±Õ¥¬¥¹É¾²Á¤ÏÂ礭¤Ê°ÕÌ£¤ò¤â¤Ä¤³¤È¤Ë¤Ê¤ë¡¥ ¤Þ¤¿½ÅÅÙ¤ÎIUGR»ù¤ËÂФ·¤Æ¡¤NST¤äĶ²»Çȥɥץé·ìή®ÅÙÇÈ·Á·×¬¤Ë²¿¤é¤«¤Î½ê¸«¤¬½Ð¸½¤¹¤ë¤Þ¤Ç½¾Íè¤É¤ª¤ê¤Ë·Ð²á´Ñ»¡¤·¤Æ¤¤¤ë´Ö¤Ë¡¤¿À·Ð³ØŪ¾ã³²¤¬½ù¡¹¤Ë¿Ê¹Ô¤·¤Æ¤¤¤ë¤³¤È¤¬¾ÚÌÀ¤µ¤ì¤ì¤Ð¡¤PUBS¤Ë¤è¤ë·ì±Õ¥¬¥¹É¾²Á¤Ï¤³¤Î¾ì¹ç¤â¤ä¤Ï¤êÎ×¾²Åª¤Ë½ÅÍפÊÌò³ä¤ò¤â¤Ä¡¥¤½¤Î²ÄǽÀ­¤Ï½½Ê¬¹Í¤¨¤é¤ì¤ë¡¥

¡¡

 Ê¸¡¡¸¥

  • 1. Huch A, Huch R, Rooth G: Guidelines for blood sampling and measurement of pH and blood gas values in obstetrics. Eur J obstet Gynecol Reprod Biol 1994;54:165-175
  • 2. LowJA: The role of blood gas and acid-base assessment in the diagnosis is of intrapartum fetal asphyxia. Am J Obstet Gynecol 1988;159:1235-1240
  • 3. Riley RJ, Johnson JW: Collectiong and analyzing cord blood gases. Clin Obstet Gynecol 1993;36:13-23
  • 4. Ruiz BC, Tucker W, Kirby RR: A program for calculation of intrapulmonary shunts, blood-gas and acid-base values with a programmable calculator. Anesthesiology 1975;42:88-95
  • 5. ¼¼·î½ß¡¤²¬Â¼½£ÇÌðÅèæ⡧ÂÛ»ùºÎ·ì¤ÎŬ±þ¤È¼ÂºÝ¡¥Î×¾²ÉؿͲʻº²Ê1993;47:1344-1346
  • 6. ¹âÎÓ½Óʸ¡¤¾®¼Äδ¹­¡§½ÐÀ¸Á°¿ÇÃÇ¡ÝçÁÂÓ·ì¡¥¿ÞÀ⻺ÉؿͲÊVIEW37¡¤½ÐÀ¸Á°¿ÇÃǤÈÂÛ»ù¼£ÎÅ¡ÊÎ뿹·°¡¤ÀéÍÕ´î±ÑÊÔ)¡¥ 1999; pp100-108¡¤ ¥á¥¸¥«¥ë¥Ó¥å¡¼¼Ò¡¤Åìµþ
  • 7. DAffos F: Fetal blood sampling. The Unborn Patient (Harrison MR, Golbus MS, Filly RA, eds). 2nd ed. 1990; pp75-81, W.B. Saunders, Philadelphia
  • 8. Weiner CP, Wenstrom KD, et al: Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol 1991;165:1020-1025
  • 9. Nicolaides KH, Economides DL, Soothill PW: Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 1989;161:996-1001
  • 10. Okamura K, Murotsuki J, et al: Relation between fetal blood gas and the outcome of babies in severe preeclampsia. Tohoku J Exp Med 1992;167:279-285
  • 11. Soothill PW, Nicolaides KH, et al: Effect of gestational age on fetal and intravillous blood gas and acid-base values in human pregnancy. Fetal Ther 1986;1:168-175
  • 12. Hobbins J, Grannum PA, et al: Percutaneous umbilidal blood sampling. Am J Obstet Gynecol 1985;152:1-6
  • 13. Nicolaides KH, Soothill PW, et al: Ultrasound-guided sampling of umbilical cord and placental bood to assess fetal well-being. Lancet 1986;i:1065-1067
  • 14. Ferazzi E, Pardi C, Bauscaglia M: The correlation of biochemical monitoring versus umbilical velocity measurements of the human fetus. Am J Obstet Gynecol 1988:159:1081-1087
  • 15. Weiner CP, Williamson RA: Evaluation of severe growth retardation employing cordocentesis: Hematologic and metabolic alterations by etiology. Obstet Gynecol 1989;73:225-229
  • 16. Bilardo CM, Nicolaides KH, Campbell S: Doppler measurements of fetal and uteroplacental circulation: Relationship with umbilical venous blood gases measured at cordocentesis. Am J Obstet Gynecol 1990;162:115-120
  • 17. Soothill PW, Nicolaides KH, et al: Uteroplacental blood velocity resistance index and umbilical venous PO2, PCO2, pH, lactate and erythroblast count in growth-retarded fetuses. Fetal Ther 1986;1:176-179
  • 18. Pardi C, Buscaglia M, et al: Cordo sampling for the elevation of oxygenetion and acid-base balance in growth-retarded human fetuses. Am J Obstet Gynecol 1987;157:1221-1228
  • 19. Soothill PW, Nicolaides KH, Campbell S: Prenatal asphyxia, hypercapnia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J 1987;294:1051-1053
  • 20. Economides DL, Crook D, et al: Investigation of hypertriglycaemia in small-for-gestational age fetuses. Fetal Ther 1988;3:165-172
  • 21. Visser GH, Sadovsky G, Nicolaides KH: Antepartum heart rate patterns in small-for gestational-age third-trimester fetuses: Correlation with blood gas values obtained at cordocentesis. Am J Obstet Gynecol 1990;162:698-703
  • 22. Shah DM, Boehm FH: Fetal blood gase analysis from cordocentesis for abnormal fetal heart rate patterns. Am J Obstet Gynecol 1989;161:374-376
  • 23. Shalve E, Dan U, et al: Sonography-guided fetal blood sampling for pH and blood gases in premature fetuses with abnormal fetal heart rate traces. Acta Obstet Gynecol Scand 1991;70:539-542
  • 24. Donner C, Vermeylen D, et al: Management of the growth-restricted fetuses: The role of non-invasive tests and fetal blood sampling. Obstet Gynecol 1995;85:965-970
  • 25. Manning F, Snijders R, et al: Fetal biophysical profile score, correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 1993;169:755-763
  • 26. Yoon BH, Romero R, et al: Relationship between the biophysical profile score, umbilical artery Doppler velocietry, and fetal blood acid-base status determined by cordocentesis. Am J Obstet Gynecol 1993;169:1586-1594
  • 27. Weiner CP: The relationship between umbilical artery systolic/diastolic ratio and umbilical blood gas measurements in specimens obtained by cordocentesis. Am J Obstet Gynecol 1990;162:1198-1202
  • 28. Nicolaides KH, Bilardo CM, et al: Absence of end diastolic frequencies in umbilical artery: A sign of fetal hypoxia and acidosis. Br Med J 1988;297:1026-1027
  • 29. Nicolaides KH, Campbell S, et al: maternal oxygen therapy for intrauterine growth retardation. Lancet 1987;i:942-945
  • 30. Vintzileos AM, Campbell S, et al: The relationship between fetal biophysical assessment, umbilical velocimetry and fetal acidosis. Obstet Gynecol 1991;77:622-626
  • 31. Manning FA, Snijders R, et al: Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous pH. Am J Obstet Gynecol 1993;169:755-763
  • 32. Nicolini U, Nicolaides KH, et al: Limited role of fetal blood sampling in prediction of outcome in intrauterine growth retardation. Lancet 1990;336:768-772

--------------------------------------------------------------------

ÂÛ»ù¿ÇÃǤˤĤ¤¤Æ¡¡¤Ë¤â¤É¤ë

¼¼·î¸¦µæ¼¼¥È¥Ã¥×¡¡¤Ë¤â¤É¤ë

¥«¥¦¥ó¥¿¡¡59453¡Ê2017ǯ7·î7Æü¤è¤ê¡Ë}}